GANODERMA RESINACEUM KFRI-M101 AND COMPOSITION FOR IMPROVING AND PREVENTING DIABETES MELLITUS USING THIS

摘要

PURPOSE: A composition containing Ganoderma resinaceum KFRI-M101(KFCC 11429P) is provided to increase AMPK activity, to lower blood glucose, and prevent and treat diabetes. CONSTITUTION: A Ganoderma resinaceum KFRI-M101(KFCC 11429P) is used for metabolism of ginsenoside ingredient. A composition for preventing and treating contains ginseng fermentation which is obtained by fermenting ginseng with Ganoderma resinaceum KFRI-M101(KFCC 11429P) at 20°C-30°C and 40-80% of moisture for 2-8 weeks. The composition also contains ginseng extract as an active ingredient, which is obtained by isolating the ginseng fermentation with water, ethanol, or mixture thereof at 90-110°C for 2-4 hours. The composition is a health food.